- Open Access
The antiestrogen ICI 182,780 induces early effects on the adult male mouse reproductive tract and long-term decreased fertility without testicular atrophy
© Cho et al; licensee BioMed Central Ltd. 2003
- Received: 03 July 2003
- Accepted: 18 August 2003
- Published: 18 August 2003
Estrogen receptors (ER) have important physiological roles in both the female and male reproductive systems. Previous studies using the estrogen receptor-α knockout mouse (αERKO) or antiestrogen treatment in adult rodents have shown that ERα is essential for normal function of the male reproductive tract. In the present study, time-response effects of the antiestrogen ICI 182,780 were determined to better understand ERα function in the adult male.
Adult male mice, 30 days old, were injected subcutaneously with ICI 182,780 (5 mg) once per week for 17 weeks. Tissues were fixed by vascular perfusion to study the time responses from day 2 to 125 post treatment.
No difference was seen in body weight due to treatment. Testis weight was decreased 18% on day 59 and 21.4% on day 125. Other significant treatment-related effects included the following: 1) dilation of rete testis and efferent ductule lumen; 2) decreased height of the rete testis and efferent ductule epithelium; 3) decreased height of the supranuclear epithelial cytoplasm in efferent ductules; 4) decreased height of the efferent ductule epithelial microvilli, particularly in the proximal ductules; 5) decrease in the PAS-positive granules and endocytotic vesicles in nonciliated epithelial cells of efferent ductules; 6) capping and vesiculation of narrow cells in the initial segment of the epididymis; 7) accumulation of PAS-positive granules in apical cells of the caput epididymis; 8) increase in lysosomal granules in clear cells of the corpus and cauda epididymis; 9) limited induction of atrophic seminiferous tubules and abnormal spermatogenesis; and 10) decreases in the concentration of cauda sperm, progressive sperm motility and decreased fertility.
Antiestrogen treatment of the pubertal male mouse resulted in reproductive effects similar to those observed in the αERKO mouse as early as day 4; however, testis weight did not increase substantially and total atrophy was not observed with extended treatment.
- Post Treatment
- Seminiferous Tubule
- Rete Testis
- Sperm Concentration
- Testis Weight
The estrogen receptor (ER)-α knockout mouse (αERKO) was the first animal model to clearly demonstrate the importance of estrogen in male reproductive tract function and fertility [1–10]. The double knockout of ERα and ERβ  and the more complete ERα knockout  confirmed that ERα is the major receptor responsible for estrogen function in male reproduction.
The major histopathological effect of ERα knockout in the male mouse reproductive tract was centered in the efferent ductules, a small region between the testis and initial segment of the epididymis [4, 5, 11]. In the αERKO male, there was a failure of efferent ductule epithelium to reabsorb fluid, which caused fluid to accumulate in the rete testis and seminiferous tubule lumen. The long-term consequence of this pathophysiology was backpressure atrophy of the testis, which lead to azoospermia. The important role of estrogen in the male reproductive tract was further demonstrated by transplanting αERKO testicular germ cells into a wild-type recipient mouse testis depleted of germ cells [12, 13]. The transplanted αERKO germ cells gave rise to offspring, thus demonstrating that αERKO sperm are capable of fertilizing eggs if the sperm travel through a wild-type reproductive tract environment.
The αERKO mouse continues to be an important animal for the study of estrogen receptor function in the male, but this transgenic animal is a developmental model, as the males lack ERα expression throughout perinatal and postnatal life. Therefore, to test the hypothesis that ERα is necessary in the adult male, and not just for development, the pure antiestrogen ICI 182,780 (AstraZeneca, Macclesfield, Cheshire, UK) was used to block ERs in the pubertal male. In the first study, mice were treated for 35 days and examined for effects. In general, it was concluded that ICI 182,780 treatment replicated most of the effects seen in the αERKO male, except for testicular atrophy and infertility .
The rat was also studied for comparison, and although there were similarities to the ICI 182,780 treated mouse, i.e., dilation of rete testis and efferent ductule lumen and decreased height of the ductal epithelium, the time-response approach used in the rat revealed considerable differences between the two species in response to the antiestrogen [14, 15]. The rat showed long-term testicular atrophy induced by fluid accumulation and testicular swelling, which led to infertility, similar to the αERKO male. Testicular and efferent ductule effects in the rat were rapid, beginning within 2–4 days after treatment. The rat efferent ductule epithelium also displayed an unusual increase in lysosomal content in the apical cytoplasm of the nonciliated cells, a response not noted after 35 days of treatment in the mouse . Therefore, several questions remained regarding antiestrogen responses in the mouse model: a) Does the mouse require a longer treatment period to show testicular atrophy? b) Is the rat more sensitive to the antiestrogen? c) Would a longer treatment period in the mouse lead to infertility? To answer these and other questions, a time-response study of ICI 182,780 treatment in pubertal male mice was conducted over a 17-week period.
Animals and experimental design
This study was conducted in three experiments to fully cover the response period to antiestrogen treatment. The first experiment examined days (d) 8–59 post treatment. Because strong effects were found on d 8, a search for the first response was conducted in an experiment that examined days 1, 2 and 4 post treatment. Infertility was not observed on d 59, therefore, a third experiment was performed to test for effects on days 100 and 125 post treatment.
Adult male C57BL/10 mice at 30 days of age were maintained under constant lighting (12 h light:12 h dark) and temperature (22°C). The University of Illinois Institutional Animal Care and Use Committee approved all experimental protocols. Food and water were available ad libitum for the experimental period. Animals were randomly divided into control (N = 3–6) and treated (N = 3–6) and injected subcutaneously with 0.1 ml of castor oil (controls) or 5 mg of ICI 182,780 (AstraZeneca, Macclesfield, UK) in 0.1 ml, each week for up to 125 days.
Control and ICI-treated mice were euthanized at specified time points out to d 125 post treatment. The animals were deeply anesthetized with xylazine/ketamine (87 mg/kg and 15 mg/kg, respectively), weighed, and then fixed by vascular perfusion with 4% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) for Histopathology. Bouin's fixative or neutral buffered formalin was perfused for immunohistochemistry. Testes, efferent ductules and the epididymides were removed and stored in the same perfusion solution at 4°C until embedded. For microscopic evaluation, tissues were weighed and then washed in cacodylate buffer, dehydrated in an ascending series of ethanol and embedded in glycol methacrylate (Hess et al, 2000). Tissue blocks were cut at 2.5 μm thickness, dried at 35°C, stained with periodic acid-Schiff reaction (PAS), counterstained with Mayer's hematoxylin and mounted for observation. Cauda epididymal sections were also stained with Coomassie blue G250, which highlights the sperm acrosome blue and the nucleus pink.
Immunohistochemistry was performed only on the efferent ductule tissues, because of its previously determined significance in the αERKO male [4, 5, 7]. Staining followed previously reported methods of antigen retrieval and indirect secondary antibody labeling [7, 16]. Antibodies included, rabbit anti-human carbonic anhydrase-II (CA-II; Chemicon International. Temecula, CA) diluted 1:1000; rabbit anti-rat sodium/hydrogen exchanger-3 (NHE3;Chemicon International. Temecula, CA) diluted 1:1000; rabbit anti-rat aquaporin-1 (AQP1) diluted 1:1000; anti-human ERα (NCL-ER-6F11; Novocastra, Newcastle upon Tyne, UK) diluted 1:1000; sheep anti-human ERβ. [S-40, ]; and rabbit anti-rat AR diluted 1:500 [PG21, [18, 19]]. Antibody binding was visualized using the avidin-biotin complex (ABC Kit, Vector Laboratories, Burlingame, CA) and diaminobenzidine (DAB). Hematoxylin was applied as a counter stain (Sigma, St. Louis, MO). Sections incubated without the primary antibody but with PBS were used as negative controls for color development on the same slide. Images were captured with a Spot II digital camera (Diagnostic Instruments, St. Sterling Heights, MI) and compiled using Adobe® Photoshop® (Adobe Systems, San Jose, CA).
Sperm Concentration and Motility
To determine sperm concentration in the cauda epididymis for the first 59 days of the study, paraffin histological sections of the distal cauda epididymis were sectioned at 20 μm thickness and stained with hematoxylin and eosin. The slides were viewed using a video camera mounted on an Olympus microscope with a plan-apochromatic 100X objective. Observed fields were selected by a systematic, uniform random sampling method, using the Stereo Investigator software, v3.0 (MicroBrightField Inc., Colchester, VT) and a motorized stage. Sperm heads were counted in a counting frame having a total of 20,000 μm3 per tubule. Ten replications per epididymis were made.
On day 125 post treatment, sperm concentrations were determined using minced cauda epididymides and a dual-sided semen analyzer system (Hamilton Thorne Research, Beverly MA). The cauda epididymis on one side of the 125 day mouse was dissected prior to perfusion and was placed in a sterile Petri dish containing 1 ml of modified Hank's Balanced Salt Solution (m-HBSS) for sperm motility analysis. The cauda was minced and incubated for 5 minutes at 37°C to allow sperm to swim into the media. At the end of the incubation time, a 100 μl sample of the media containing the sperm was diluted with 900 μl of the m-HBSS solution for sperm analysis. Each sperm analysis chamber was loaded with 14 μl of the diluted sperm by capillary action. Analysis chambers were immediately placed into the specimen holder of TOX-IVOS computer assisted sperm analysis system that had been calibrated for mouse sperm samples. The samples, chambers and specimen holder were maintained at 37°C throughout the entire measurement period. Six fields were analyzed from each of the two chambers and the results averaged.
Tissues were photographed using a Spot-II digital camera mounted on an Olympus Microscope and Plan-apochromatic lenses (Olympus America Inc, NY) and saved in Adobe Photoshop (Adobe Systems, Inc., San Jose, CA). Morphometry data from days 8, 16, 59 and 125 post treatment are included. The digital images from both reproductive tracts of 3 control and 3 ICI-treated animals on each post treatment day were analyzed by Scion Image Software (Scion Corporation, Frederick, MD). Luminal diameter of 10 seminiferous tubules (stages VII-VIII) was determined per mouse per testis, by measuring the widest diameter in cross-section. However, for day 125 all seminiferous tubules per testis were measured for diameter because some tubules were atrophic and stage of spermatogenesis was not determined. Luminal diameter of the rete testis was determined in 3 testes per treatment group. Luminal diameter of proximal efferent ductules was determined in 5 sections per mouse. Cell height was measured from the base to the apex in 30 epithelial cells of the rete testis region, or to the microvillus tip in 30 nonciliated cells from non-oblique sections of the proximal efferent ductules per mouse. The supranuclear cytoplasmic height was determined by measurement from the top of the nucleus to the microvillus tip in the nonciliated cells in the proximal efferent ductules.
Individual mice of control and ICI-treated groups on day 50, day 93, or day118 after treatment were mated with 3 female mice of the same age and strain for one week, then separated. One week after separation, the females were euthanized by sodium pentobarbital injection and the uterine horns opened. The number of embryos, number of implantation sites and resorptions/stillbirths were counted. If at least one female per mating had live births, the male was considered fertile. Subfertility was indicated by a reduction in the number of live births or an increase in the number of resorptions.
Data are presented as means ± SEM. To compare morphological differences between controls and treatment groups, means were analyzed by two-way ANOVA followed by individual paired t-test for each time point (P < 0.05). Proportion data were analyzed by the chi-square test with a probability of less than 5% considered significant.
Body and organ weights
Effects of ICI 182,780 on body and testis weight.a
Testis Weight (mg)
Day of treatment
Weight (g) ICI-Treated
17.99 ± 2.22
19.8 ± 1.17
71.4 ± 1.81
83.2 ± 5.87
16.48 ± 0.81
22.66 ± 0.42
68.0 ± 2.96
78.9 ± 4.33
19.74 ± 1.58
24.41 ± 1.43
85.1 ± 2.49
90.9 ± 0.86
22.17 ± 0.98
21.57 ± 0.15
91.0 ± 3.40
91.0 ± 2.93
22.65 ± 0.46
24.3 ± 0.15
84.9 ± 1.40
96.3 ± 1.70b
25.67 ± 0.66
26.11 ± 0.56
96.5 ± 2.59
94.6 ± 2.85
26.63 ± 0.44
30.19 ± 1.27
128.7 ± 5.37
105.0 ± 7.03b
29.97 ± 0.45
31.97 ± 0.78
95.2 ± 2.58
74.8 ± 4.75b
Testis and rete testis
PAS positive lysosomal granules were numerous in the supranuclear cytoplasm of control nonciliated cell in the proximal region (Fig. 8A,8C,8E). The conus and common regions in control animals contained fewer lysosomal granules (data not shown). ICI 182,780 treatment caused a reduction in the number of lysosomes and vesicles in all regions, but in some regions the effect was more dramatic (Fig. 8B,8D,8F). The reduction in lysosomes was associated with a decrease in supranuclear cytoplasm (Fig. 9). With decreased height of the epithelium, the nuclear shape was changed from nearly round or slightly columnar (controls) to a more flattened morphology (Fig. 8).
Efferent ductule immunohistochemistry
Reproductive performance in mice after antiestrogen treatmenta.
Percent Progressive Sperm Motility
34.5 ± 2.90%
7.2 ± 3.11%b,c
Average litter size
8.0 ± 0.8
5.80 ± 1.3e
Percentage of Resorptions/fetal deaths
12.3 ± 1.1%
20.67 ± 1.7%c
The present study demonstrates that the mouse ICI 182,780 treatment model, when extended from 4 days to 125 days post treatment, resembles the αERKO model in nearly every feature, except for the transient increase in testis weight and testicular atrophy. The decrease in sperm concentration in cauda epididymis and luminal dilation of the rete testis and efferent ductules following treatment clearly support the overall hypothesis that a functional ERα is required for normal fluid reabsorption in the efferent ductules, as concluded from prior studies of the αERKO male [4, 7].
In the present model, treatment was started at 30 days of age. This age represents early puberty and the males were still growing, as evidenced by the increase in body and testis weights in controls and treated animals over the next 60 days. Except for an unexplained difference in testis weight on day 16 post treatment, there was no effect on testis weight out to day 25, similar to a previous short-term study . However, on day 59 of treatment testis weight differences began to appear, with a decrease in the treated animals. Thus, with a longer treatment period the mouse showed limited atrophy of seminiferous tubules, but not total atrophy as seen in the αERKO males .
At the beginning of puberty, spermatogenesis appears normal in the αERKO testis, but as the male ages seminiferous tubules begin to degenerate . The αERKO testis weight nearly doubles in approximately 40 days, starting at puberty; then testis weight declines and eventually total testicular atrophy occurs at 185 days of age . ICI 182,780 treatment in the rat induces a similar pattern of effect, with both testicular swelling and long-term atrophy of the testis, nearly identical to the αERKO male [14, 15]. Why the mouse testis did not respond with a similar increase in testis weight and then atrophy remains a major question. However, the rete testis was dilated in the mouse, as in αERKO and ICI-treated rat males, suggesting that ability of the mouse testis to handle fluid accumulation is dependent upon developmental factors that are lacking in the αERKO male. One possibility is that the mouse epididymis is capable of compensatory reabsorption of the excess fluid. Future studies are required to understand these differences in response.
The effects observed on spermatogenesis did not appear to be due to fluid accumulation because there was no dilation of the seminiferous tubular lumen, in contrast to what was discovered in the αERKO testis . Furthermore, abnormal spermatogenesis did not occur until day 59, suggesting that the degenerative process required long-term inhibition of ER. Because ICI 182,780 blocks both ERα and ERβ , the delayed testicular response may be due to ICI's inhibition of ERβ and not ERα. ERα is not expressed in the seminiferous epithelium, but ERβ is abundant in Sertoli and germ cells [16, 21–25]. Therefore, ICI's effects on the epithelium may be through long-term inhibition of ERβ. It is interesting that the aromatase knockout mouse also shows a delayed disruption of spermatogenesis [26, 27], similar to the effects of ICI 182,780 in the mouse testis. Although the ERβ knockout mouse shows no apparent phenotype [3, 10, 28], in light of the current findings, it would be worthwhile to examine the βERKO male for specific aging effects on the testis.
Dilation of the rete testis lumen was less extensive following ICI 182,780 treatment, compared to the αERKO mouse . The present study demonstrated that this effect begins sooner than previously thought, with dilation being observed on day 10. On the other hand, the rete epithelium was reduced in height as early as day 8. It is assumed that the decrease in epithelial height is related to the accumulation of luminal fluid; however, it may also be due to overgrowth of the rete epithelium because neonatal exposure to environmental estrogens has produced a similar dilation and overgrowth of the rete testis [29, 30].
A prior study did not find these early effects of ICI 182,780 treatment . However, here we report effects as early as day 4, at which time proximal regions of the efferent ductules were dilated. This observation is important because the dilatation did not induce a reduction in epithelial cell height, suggesting that the two effects are not directly linked. Others have suggested that the decrease in epithelial height is due to alterations in ion transporter expression , but the present study does not support this hypothesis, as fluid reabsorption detected by luminal dilation occurred without a decrease in epithelial height. Other early effects were subsequent reduction in efferent ductule epithelial height (day 8) and protrusion of the narrow cells in the epididymis. Effects on the testis were not observed until much later. These early morphological effects were maintained throughout the 125-day treatment period and are in agreement with our previous studies of αERKO mouse [4, 5] and ICI 182,780 treatment in mice . Thus, it may be possible to use the mouse antiestrogen treatment model during shorter periods of treatment for the study of fluid dynamics within the efferent ductules, but also to study testicular effects that require more than 50 days of exposure.
Overall effects of ICI 182,780 on the mouse efferent ductules were identical to those observed in the αERKO male, including the loss of NHE3 staining and decrease in staining for AQP-1 and CAII . These data further support the hypothesis that estrogen's regulation of sodium transport by this epithelium is essential for maintenance of fluid reabsorption. Antiestrogen treatment also caused a decrease in ERα staining, which has been reported in female tissues , but the compound had no effect on ERβ.
The effects noted in epididymis could be due to direct action of ICI on the epididymal epithelium, as recent studies have shown that ERα is expressed more extensively in the epididymis of the mouse , than in the rat . Cell types that responded to treatment, the narrow and apical cells of initial segment, apical cells of the caput, and clear cells of the corpus and cauda, are all strongly ERα-positive . In the ICI treated group, apical vesicles in the narrow cells and vesicles in clear and principal cells in corpus and distal caudal epididymis were increased in size and number. An accumulation of large PAS-positive granules was also observed in the apical cells of the caput. These findings are nearly identical to epididymal changes seen in αERKO  and may indicate an attempt to increase reabsorption of fluid by the epididymis, to compensate for reduced reabsorption found in the proximal region of the efferent ductules [4, 7].
In the control animals, epididymal sperm concentrations reached their peak on day 59, showing a gradual increase starting at 38 days of age. However, the ICI treated group did not experience this normal increase in sperm concentration and beginning on day 16 showed a divergence from controls so that on days 59 and 125 post treatment there were decreases of 30 and 41%, respectively. These differences are considerably more than the 22% decline seen in αERKO males . On day 25 (data not shown), there was a 12.4% decline in sperm concentration, which was similar to our previous experiment, which showed an 11% decrease after 35 days of antiestrogen treatment . Thus, the overall trend in the mouse antiestrogen treatment model is for increasing dilution of cauda sperm and accumulation of fluids in the efferent ductules and testis. It is noteworthy that the decrease in fertility did not occur until day 125 post treatment, the time period that coincided with the maximum decrease in sperm concentration. In the rat, decreased fertility coincided with the onset of testicular atrophy [14, 15], therefore it was questioned whether infertility and subfertility was due to abnormal sperm maturation due to dilution in the epididymis or if atrophy of the seminiferous epithelium was required before sperm concentrations could reach levels that would produce infertility. The current study suggests that subfertility in the mouse antiestrogen treatment model is related to the sperm dilution effects that occur in the epididymis, which appears to induce abnormal maturation of the cauda sperm. Even in the αERKO male, testicular sperm are fertile when transplanted into germ cell depleted normal testes [12, 13], which suggests that the epididymal environment is one of the more important factors leading to infertility in the absence of ERα expression in the male.
The antiestrogen, ICI 182,780 induces very early effects on rete testis, efferent ductules and epididymis, which resemble morphological changes observed in the αERKO male. These early effects are maintained throughout the treatment period of 125 days and thus, suggest that a much shorter model of 4–8 days of treatment may be used to study the role of estrogen in fluid reabsorption in the male tract. Although the inhibition of estrogen receptors for 125 days induced structural and physiological changes in the reproductive tract, it did not induce total testicular atrophy, but did cause a decrease in fertility and showed evidence of early induction of abnormal spermatogenesis. Thus, it is possible to induce infertility by blocking ER function in the male, without causing azoospermia. If such treatment effects are observed at lower dosages and if the responses are reversible, it should be possible in the future to target ERα for male contraception.
We are grateful for the generous supply of ICI 182,780 provided by AstraZeneca, Macclesfield, UK. Supported by NIH grant number HD35126 (RAH) and partially supported by the Foundation of Sunchon National University (H.W.C) and CONRAD.
- Eddy EM, Washburn TF, Bunch DO, Goulding EH, Gladen BC, Lubahn DB, Korach KS: Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinol. 1996, 137: 4796-4805. 10.1210/en.137.11.4796.Google Scholar
- Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O: Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA. 1993, 90: 11162-11166.PubMed CentralView ArticlePubMedGoogle Scholar
- Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M: Effect of single and compound knockouts of estrogen receptors a (ER a) and b (ER b) on mouse reproductive phenotypes. Development. 2000, 127: 4277-4291.PubMedGoogle Scholar
- Hess RA, Bunick D, Lee KH, Bahr J, Taylor JA, Korach KS, Lubahn DB: A role for oestrogens in the male reproductive system. Nature. 1997, 390: 509-512. 10.1038/37352.View ArticlePubMedGoogle Scholar
- Hess RA, Bunick D, Lubahn DB, Zhou Q, Bouma J: Morphologic changes in efferent ductules and epididymis in estrogen receptor-alpha knockout mice. J Androl. 2000, 21: 107–121-PubMedGoogle Scholar
- Nakai M, Bouma J, Nie R, Zhou Q, Carnes K, Jassim E, Lubahn DB, Hess RA: Morphological analysis of endocytosis in efferent ductules of estrogen receptor-alpha knockout male mouse. Anat Rec. 2001, 263: 10-18. 10.1002/ar.1071.View ArticlePubMedGoogle Scholar
- Zhou Q, Clarke L, Nie R, Carnes K, Lai LW, Lien YH, Verkman A, Lubahn D, Fisher JS, Katzenellenbogen BS, Hess RA: Estrogen action and male fertility: Roles of the sodium/hydrogen exchanger-3 and fluid reabsorption in reproductive tract function. Proc Natl Acad Sci U S A. 2001, 98: 14132-14137. 10.1073/pnas.241245898.PubMed CentralView ArticlePubMedGoogle Scholar
- Lee KH, Finnigan-Bunick C, Bahr J, Bunick D: Estrogen Regulation of Ion Transporter Messenger RNA Levels in Mouse Efferent Ductules Are Mediated Differentially Through Estrogen Receptor (ER) alpha and ERbeta. Biol Reprod. 2001, 65: 1534-1541.View ArticlePubMedGoogle Scholar
- Lee KH, Hess RA, Bahr JM, Lubahn DB, Taylor J, Bunick D: Estrogen receptor alpha has a functional role in the mouse rete testis and efferent ductules. Biol Reprod. 2000, 63: 1873-1880.View ArticlePubMedGoogle Scholar
- Couse JF, Hewitt SC, Bunch DO, Sar M, Walker VR, Davis BJ, Korach KS: Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta. Science. 1999, 286: 2328-2331. 10.1126/science.286.5448.2328.View ArticlePubMedGoogle Scholar
- Hess RA, Zhou Q, Nie R: The Role of Estrogens in the Endocrine and Paracrine Regulation of the Efferent Ductules, Epididymis and Vas deferens. The Epididymis: from Molecules to Clinical Practice. Edited by: Robaire B and Hinton B T. 2002, New York, Kluwer Academic/Plenum Publishers, 317-338.View ArticleGoogle Scholar
- Mahato D, Goulding EH, Korach KS, Eddy EM: Estrogen receptor-alpha is required by the supporting somatic cells for spermatogenesis. Mol Cell Endocrinol. 2001, 178: 57-63. 10.1016/S0303-7207(01)00410-5.View ArticlePubMedGoogle Scholar
- Mahato D, Goulding EH, Korach KS, Eddy EM: Spermatogenic cells do not require estrogen receptor-alpha for development or function [see comments]. Endocrinology. 2000, 141: 1273-1276. 10.1210/en.141.3.1273.PubMedGoogle Scholar
- Oliveira CA, Carnes K, Franca LR, Hess RA: Infertility and testicular atrophy in the antiestrogen-treated adult male rat. Biol Reprod. 2001, 65: 913-920.View ArticlePubMedGoogle Scholar
- Oliveira CA, Zhou Q, Carnes K, Nie R, Kuehl DE, Jackson GL, Franca LR, Nakai M, Hess RA: ER Function in the Adult Male Rat: Short- and Long-Term Effects of the Antiestrogen ICI 182,780 on the Testis and Efferent Ductules, without Changes in Testosterone. Endocrinology. 2002, 143: 2399-2409. 10.1210/en.143.6.2399.View ArticlePubMedGoogle Scholar
- Nie R, Zhou Q, Jassim E, Saunders PT, Hess RA: Differential expression of estrogen receptors a and b in the reproductive tracts of adult male dogs and cats. Biol Reprod. 2002, 66: 1161-1168.View ArticlePubMedGoogle Scholar
- Saunders PT, Millar MR, Williams K, Macpherson S, Harkiss D, Anderson RA, Orr B, Groome NP, Scobie G, Fraser HM: Differential expression of estrogen receptor-alpha and -beta and androgen receptor in the ovaries of marmosets and humans. Biol Reprod. 2000, 63: 1098-1105.View ArticlePubMedGoogle Scholar
- Prins GS: Neonatal estrogen exposure induces lobe-specific alterations in adult rat prostate androgen receptor expression. Endocrinology. 1992, 130: 3703-3714. 10.1210/en.130.6.3703.View ArticlePubMedGoogle Scholar
- Prins GS, Birch L: The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen. Endocrinology. 1995, 136: 1303-1314. 10.1210/en.136.3.1303.PubMedGoogle Scholar
- Howell A, Osborne CK, Morris C, Wakeling AE: ICI 182,780 (Faslodex): development of a novel, "pure" antiestrogen. Cancer. 2000, 89: 817-825. 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.3.CO;2-Y.View ArticlePubMedGoogle Scholar
- Zhou Q, Nie R, Prins GS, Saunders PT, Katzenellenbogen BS, Hess RA: Localization of androgen and estrogen receptors in adult male mouse reproductive tract. J Androl. 2002, 23: 870-881.PubMedGoogle Scholar
- Saunders PT, Fisher JS, Sharpe RM, Millar MR: Expression of oestrogen receptor beta (ER beta) occurs in multiple cell types, including some germ cells, in the rat testis. J Endocrinol. 1998, 156: R13-7.View ArticlePubMedGoogle Scholar
- Saunders PTK, Maguire SM, Gaughan J, Millar MR: Expression of oestrogen receptor beta (ER-beta) in multiple rat tissues visualised by immunohistochemistry. Journal of Endocrinology. 1997, 154: R 13-R 16.View ArticleGoogle Scholar
- Goyal HO, Bartol FF, Wiley AA, Neff CW: Immunolocalization of receptors for androgen and estrogen in male caprine reproductive tissues: unique distribution of estrogen receptors in efferent ductule epithelium. Biol Reprod. 1997, 56: 90-101.View ArticlePubMedGoogle Scholar
- Fisher JS, Millar MR, Majdic G, Saunders PT, Fraser HM, Sharpe RM: Immunolocalisation of oestrogen receptor-alpha within the testis and excurrent ducts of the rat and marmoset monkey from perinatal life to adulthood. J Endocrinol. 1997, 153: 485-495.View ArticlePubMedGoogle Scholar
- Vaillant S, Magre S, Dorizzi M, Pieau C, Richard-Mercier N: Expression of AMH, SF1, and SOX9 in gonads of genetic female chickens during sex reversal induced by an aromatase inhibitor. Dev Dyn. 2001, 222: 228-237. 10.1002/dvdy.1190.View ArticlePubMedGoogle Scholar
- Robertson KM, O'Donnell L, Simpson ER, Jones ME: The phenotype of the aromatase knockout mouse reveals dietary phytoestrogens impact significantly on testis function. Endocrinology. 2002, 143: 2913-2921. 10.1210/en.143.8.2913.View ArticlePubMedGoogle Scholar
- Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA, Smithies O: Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA. 1998, 95: 15677-15682. 10.1073/pnas.95.26.15677.PubMed CentralView ArticlePubMedGoogle Scholar
- Aceitero J, Llanero M, Parrado R, Pena E, Lopez-Beltran A: Neonatal exposure of male rats to estradiol benzoate causes rete testis dilation and backflow impairment of spermatogenesis. Anat Rec. 1998, 252: 17-33. 10.1002/(SICI)1097-0185(199809)252:1<17::AID-AR3>3.3.CO;2-G.View ArticlePubMedGoogle Scholar
- Fisher JS, Turner KJ, Brown D, Sharpe RM: Effect of neonatal exposure to estrogenic compounds on development of the excurrent ducts of the rat testis through puberty to adulthood. Environ Health Perspect. 1999, 107: 397-405.PubMed CentralView ArticlePubMedGoogle Scholar
- Howell A: Faslodex (ICI 182780). an oestrogen receptor downregulator. Eur J Cancer. 2000, 36: S87-8. 10.1016/S0959-8049(00)00241-0.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.